ganoderenic acid A
Identification
| Name | ganoderenic acid A |
| CAS Number | 100665-40-5 |
| FDA UNII | Search |
| Molecular Formula | C30 H42 O7 |
| Molecular Weight | 514.65914000 |
Regulatory
Physical Properties
| Assay | 95.00 to 100.00 |
| Food Chemicals Codex Listed | No |
| Soluble in | water, 1.316 mg/L @ 25 °C (est) |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | natural substances and extractives |
| Recommendation for ganoderenic acid A usage levels up to | not for fragrance use. |
| Recommendation for ganoderenic acid A flavor usage levels up to | not for flavor use. |
BOC Sciences
Best of Chemicals Supplier
Quality supplier of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecul...
Potential Uses
Natural Occurrence
Synonyms
(E)-6-[(7S,10S,13R,14R,15S,17R)-7,15-
dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid
lanosta-8,20(22)-dien-26-oic acid, 7,15-dihydroxy-3,11,23-trioxo-, (7beta,15alpha,20E)-
PubMed:
Network pharmacology analysis of the anti-cancer pharmacological mechanisms of Ganoderma lucidum extract with experimental support using Hepa1-6-bearing C57 BL/6 mice.
PubMed:
[Determination of nine triterpenoid acids from Ganoderma lucidum of different producting areas by HPLC].
PubMed:
Inhibition of aldose reductase in vitro by constituents of Ganoderma lucidum.
PubMed:
[Simultaneous HPLC determination of four triterpenoid acids in Ganoderma lucidum].
PubMed:
Beta-glucuronidase-inhibitory activity and hepatoprotective effect of Ganoderma lucidum.